SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?


To: atticus4paws who wrote (434)11/1/2018 11:19:52 AM
From: scaram(o)uche  Respond to of 684
 
Sorry, haven't looked at tril abstract. Was referring to afmd-related abstracts, Amphivena work and two afmd molecules.

I'll look, but need to walk a dog.

;-)



To: atticus4paws who wrote (434)11/1/2018 11:47:54 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 684
 
The total number of doses is given underneath each bar in the chart.



To: atticus4paws who wrote (434)11/1/2018 11:50:35 AM
From: scaram(o)uche  Respond to of 684
 
>> Is it more about saturation over time versus total dose received <<

Beyond a minimum effective dose, I'd say/guess yes. There are several patients shown who rec's one dose, obviously in a single lesion.